close
ASIAN (E)

Nigeria's entertainment sector ripe for private equity

no thumb


The time has arrived for private equity (and venture capital) investment to begin to flow into certain strategic segments of the Nigerian Entertainment and Media sector, according to Olumide Mustapha, a media and entertainment attorney.

Gold mine

Entertainment and media (E&M) is a gold mine of a business that is equally precarious in the most advanced economies, not to mention developing markets.

E&M refers to commercial activities related to the production, marketing, distribution, broadcast, licensing or other exploitation of media and entertainment assets- such as music, films/TV shows, video games and other multimedia content. The increasing convergence of media and entertainment with telecommunications and technology is a key growth driver of the sector globally.

Given the maturity of the developed entertainment markets in the West, investors are beginning to turn towards the huge (and for all intents and purposes untapped) Asian and African markets respectively.

The potentials of the Asian entertainment markets have been clearly recognised with investment firms having already positioned themselves to capitalize on the anticipated growth. For example, in India, KKR and Chernin Group formed a joint fund, Emerald Media, to invest specifically in digital E&M businesses. Similar strategies can also be seen in Singapore and South Korea.

And it is not just the increased investment that is eye-catching; returns have also been positive. According to investment analysts Venture Intelligence, E&M investment in Asian markets in 2015 hit a record high of just under $90 million, with a corresponding record number of exits valued at $294 million at an average return ranging between 20 and 25 percent.

On the other hand the Nigerian E&M markets (and those across Africa generally – South Africa excluded) are still only in their earliest stages of development. Despite total private equity investment in Africa seeing a steady increase over the last few years – with $3.8 billion invested across the continent over the course of 2016 – very little of that investment (less than 1 percent) has gone into E&M anywhere across the continent let alone Nigeria.

Market Value

The overall value of the Nigerian E&M sector, especially when held up against other comparable developing E&M markets, can be perceived as significantly lacking in value.

According to Price Waterhouse Cooper’s “Entertainment and Media Outlook: 2017-2021” report, the combined total estimated value of the music and film segments of Nigeria’s E&M sector is circa $3.2 billion. When compared to South Korea ($11.6 billion) or South Africa ($9 billion), it is clear that the Nigerian E&M market still has a significant value gap to bridge. However, in light of strong market indicators, this gap is expected to be significantly reduced in the short to medium term.

Domestically, despite some macroeconomic volatility, there are positive demographic factors and socioeconomic trends that bode well. These factors and trends have been well documented and can be summarised as follows: a youthful, aspirational and increasingly urbanised population that is growing at an exponential rate. Moreover, increasing mobile and internet penetration further strengthens the domestic opportunities. Combine these indicators with the increasing consumption power and appetite of a growing middle class, and the possibilities become clearer.

Foreign market opportunities also look bright. Nigerian cultural products and services are increasingly gaining export value particularly due to increasing numbers of diaspora-Nigerians spending more on and more of their incomes on homegrown entertainment. Furthermore, strengthened African influence on global popular culture means demand for Nigerian entertainment products will only increase abroad.

For example, popular Nigeria based performers are now selling out major venues around the world and Nigeria based digital content producers and distributors are finding that an increasing portion (if not the majority) of their audience/users/subscribers are based in Europe, Asia and the United States.

Investment Opportunities

It is the author’s considered view that the time has arrived for private equity (and venture capital) investment to begin to flow into certain strategic segments of the Nigerian E&M sector.

Recent currency devaluations, despite being perceived as having an adverse effect on institutional investor appetite for investments in Nigeria, have actually presented an opportunity for investors to gain stakes in well positioned media and entertainment businesses at much better rates thereby reducing risk and positioning themselves for potentially much higher returns. E&M investments provide the best opportunities for large returns with minimal risk to investors who have (access to) specialised expertise in, and knowledge of, the market.

And the opportunities are tremendous. Iroko Partners Ltd, whose core business Iroko TV (a video on demand subscription service (SVOD)), has successfully raised $40 million till date with backers including Kinnevik, RISE and Tiger Global. Furthermore, some seed investors exited with returns of over 3000% on their investments after an average investment hold period of around 4-5 years. The business has since expanded to integrate an audiovisual production arm into its operations in addition to launching television channels both in Nigeria and the UK. It recently also announced that for the first time the majority of its revenues came from outside Nigeria.

When one considers that the majority of private equity investments in Africa in 2016 alone were investments of less than $50 million, small investments (ranging from $500k – $2 million) in viable businesses such as this, and others in the Nigerian E&M sector, seem a very worthwhile prospect when potential returns are weighed against risks.

Conclusion

In conclusion, there is an increasing opportunity for private equity investment to generate significant returns in the Nigerian E&M sector for investors that have (access to) information and insights related to the sector based on local knowledge and expertise. The film/TV/SVOD segment in particular is ripe for private equity investment at this time. Given the demand for content in this segment and the relatively capital intensive requirments to produce same, the patient nature of private equity capital makes such type of funding a better fit than Venture Capital – which in the author’s view is better suited for music sector investments. Based on growth projections over the next five years, any private equity investments made in the film/TV/SVOD segment at this point in time will very likely see impressive returns at the point of exit (shoult the usual hold periods of 5-6 years apply).

Private equity firms must begin to actively look into the available opportunities and engage suitable local advisors with specialist knowledge of the sector to guide them along the narrow path towards the proverbial pot of gold at the end of the rainbow.



Source link

read more
INDIAN (H)

Three more hospitals get approval for anti-TB wonder drug treatment

no thumb


Representative image
Representative image

A year after the successful trial of a wonder drug used in the treatment of drug-resistant Tuberculosis, the health ministry has given its approval to three more centres in the city to conduct the procedure.

Till now, 180 test subjects have responded well to the Bedaquiline treatment regimen. As a result, under the revised national tuberculosis control program (RNTCP), the health ministry gave its go-ahead to three more centres in Mumbai apart from KEM Hospital.

Now, Nair hospital in Byculla, LTMG Sion hospital, Shatabdi hospital in Govandi have been authorised for the wonder drug treatment.

The medication will be administered to a select group of patients – those diagnosed with multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains of the bacteria.

Bedaquiline, manufactured by Belgian pharma major Janssen, a subsidiary of Johnson & Johnson, received safety and effectiveness clearances from US Food and Drug Administration in December 2014 after multiple trails worldwide and is recognised by the World Health Organisation as an “essential drug” in treating TB. A sixmonth course of the medication will cost the government Rs 2 lakh per patient.

In 2016, under the RNTCP programme the health ministry had started Bedaquiline trials at six public health facilities — namely the National Institute of Research in Tuberculosis (NIRT), Chennai; the National Institute of TB and Respiratory Diseases (NITRD), New Delhi; Rajan Babu Institute for Pulmonary Medicine and Tuberculosis, New Delhi; Sewri Hospital, Mumbai; BJ Medical College & Hospital, Ahmedabad and Government Medical College, Guwahati to treat 600 patients.

In Mumbai, so far, 180 drug resistance patients have benefited under the supervision of KEM Hospital doctors.

Elaborating on the course, Dr Daksha Shah, head of the city’s TB control programme said. “We have already permitted the new centres to identify the patients eligible for Bedaquiline regimen and registered them under RNTCP. Those selected will be treated with a combination of Bedaquiline and other medications.”

She said reports detailing the medical history and documents related to the pathology of the strain of TB affecting the patients have been dispatched to the central TB division in Delhi.

“We are using the guidelines recommended by the WHO in determining the course of treatment.” Dr Shah said adding that pregnant women and children will not be part of the target recipients.

According to a recent WHO estimate, up to half a million new cases of MDR TB are reported worldwide each year. The existing treatment regimen lasts up to 20 months or more and requires daily doses of medication that is deemed “more toxic, less effective and far more expensive” when compared to Bedaquiline. The Ministry of Health and Family Welfare, in its national strategic plan, proposes to eliminate tuberculosis by 2025.

Dr Vikas Oswal, who has treated thousands of drug-resistant cases in Govandi, Mankhurd and Shivaji Nagar, told Mirror, “Earlier we used to refer the patients to KEM Hospital for Bedaquiline treatments. Now, I am glad that we can treat them in Govandi Shatabdi Hospital itself.”



Source link

read more
1 21,912 21,913 21,914 21,915 21,916 22,236
Page 21914 of 22236